Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature

Antiepiligrin cicatricial pemphigoid (AECP) is a chronic autoimmune subepidermal blistering disease characterized by clinical features of cicatricial pemphigoid and circulating IgG antibasement membrane autoantibodies directed against laminin 332. There is growing evidence of an increased relative r...

Full description

Bibliographic Details
Main Authors: Chih-Pin Chen, Richard Plunkett, Raminder Grover, Song-Jen Hong
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-06-01
Series:Dermatologica Sinica
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1027811711000334
_version_ 1818025560043945984
author Chih-Pin Chen
Richard Plunkett
Raminder Grover
Song-Jen Hong
author_facet Chih-Pin Chen
Richard Plunkett
Raminder Grover
Song-Jen Hong
author_sort Chih-Pin Chen
collection DOAJ
description Antiepiligrin cicatricial pemphigoid (AECP) is a chronic autoimmune subepidermal blistering disease characterized by clinical features of cicatricial pemphigoid and circulating IgG antibasement membrane autoantibodies directed against laminin 332. There is growing evidence of an increased relative risk for solid cancers and lymphomas in AECP patients, especially in the 1st year after the onset of blisters. However, it is difficult to distinguish patients with initially skin-predominant AECP from similar findings of epidermolysis bullosa acquisita merely based on clinical, histopathologic, and immuno-pathologic examinations. This is a report on a case of AECP confirmed by indirect immunofluorescence of type VII collagen- and laminin 332-deficient skin as substrates to differentiate it from epidermolysis bullosa acquisita.
first_indexed 2024-12-10T04:18:03Z
format Article
id doaj.art-4a89363dbc234aa69a6dc81cbff83d2b
institution Directory Open Access Journal
issn 1027-8117
language English
last_indexed 2024-12-10T04:18:03Z
publishDate 2011-06-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Dermatologica Sinica
spelling doaj.art-4a89363dbc234aa69a6dc81cbff83d2b2022-12-22T02:02:31ZengWolters Kluwer Medknow PublicationsDermatologica Sinica1027-81172011-06-01292555810.1016/j.dsi.2011.05.003Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literatureChih-Pin Chen0Richard Plunkett1Raminder Grover2Song-Jen Hong3Department of Dermatology, Buddhist Tzu-Chi General Hospital, Hualien, TaiwanDepartment of Microbiology and Immunology, School of Medicine, State University of New York at Buffalo, Buffalo, New York, NY, USADepartment of Microbiology and Immunology, School of Medicine, State University of New York at Buffalo, Buffalo, New York, NY, USADepartment of Dermatology, Buddhist Tzu-Chi General Hospital, Hualien, TaiwanAntiepiligrin cicatricial pemphigoid (AECP) is a chronic autoimmune subepidermal blistering disease characterized by clinical features of cicatricial pemphigoid and circulating IgG antibasement membrane autoantibodies directed against laminin 332. There is growing evidence of an increased relative risk for solid cancers and lymphomas in AECP patients, especially in the 1st year after the onset of blisters. However, it is difficult to distinguish patients with initially skin-predominant AECP from similar findings of epidermolysis bullosa acquisita merely based on clinical, histopathologic, and immuno-pathologic examinations. This is a report on a case of AECP confirmed by indirect immunofluorescence of type VII collagen- and laminin 332-deficient skin as substrates to differentiate it from epidermolysis bullosa acquisita.http://www.sciencedirect.com/science/article/pii/S1027811711000334Antiepiligrin cicatricial pemphigoidEpidermolysis bullosa acquisitaIndirect immunofluorescenceLaminin 332Type VII collagen
spellingShingle Chih-Pin Chen
Richard Plunkett
Raminder Grover
Song-Jen Hong
Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature
Dermatologica Sinica
Antiepiligrin cicatricial pemphigoid
Epidermolysis bullosa acquisita
Indirect immunofluorescence
Laminin 332
Type VII collagen
title Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature
title_full Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature
title_fullStr Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature
title_full_unstemmed Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature
title_short Differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking Type VII collagen or laminin 332: a case report and review of literature
title_sort differentiating antiepiligrin cicatricial pemphigoid from epidermolysis bullosa acquisita by indirect immunofluorescence of skin substrates lacking type vii collagen or laminin 332 a case report and review of literature
topic Antiepiligrin cicatricial pemphigoid
Epidermolysis bullosa acquisita
Indirect immunofluorescence
Laminin 332
Type VII collagen
url http://www.sciencedirect.com/science/article/pii/S1027811711000334
work_keys_str_mv AT chihpinchen differentiatingantiepiligrincicatricialpemphigoidfromepidermolysisbullosaacquisitabyindirectimmunofluorescenceofskinsubstrateslackingtypeviicollagenorlaminin332acasereportandreviewofliterature
AT richardplunkett differentiatingantiepiligrincicatricialpemphigoidfromepidermolysisbullosaacquisitabyindirectimmunofluorescenceofskinsubstrateslackingtypeviicollagenorlaminin332acasereportandreviewofliterature
AT ramindergrover differentiatingantiepiligrincicatricialpemphigoidfromepidermolysisbullosaacquisitabyindirectimmunofluorescenceofskinsubstrateslackingtypeviicollagenorlaminin332acasereportandreviewofliterature
AT songjenhong differentiatingantiepiligrincicatricialpemphigoidfromepidermolysisbullosaacquisitabyindirectimmunofluorescenceofskinsubstrateslackingtypeviicollagenorlaminin332acasereportandreviewofliterature